Loading...
XSWXYPSN
Market cap4.93bUSD
Jan 13, Last price  
331.00CHF
1D
-2.36%
1Q
-16.94%
Jan 2017
78.92%
Name

Ypsomed Holding AG

Chart & Performance

D1W1MN
P/E
57.58
P/S
8.23
EPS
5.75
Div Yield, %
0.39%
Shrs. gr., 5y
1.61%
Rev. gr., 5y
3.86%
Revenues
548m
+10.25%
241,823,000310,588,000277,450,000287,468,000272,580,000254,014,000242,461,000248,593,000244,565,000276,257,000306,632,000336,922,000389,555,000466,119,000453,765,000394,264,000403,656,000464,841,000497,460,000548,457,000
Net income
78m
+52.83%
39,195,00055,648,0002,742,00026,583,00026,166,0009,425,0005,206,0008,500,0001,646,00013,608,00019,395,00035,812,00046,247,00052,060,00060,136,00011,734,0005,811,00023,105,00051,275,00078,366,000
CFO
163m
+26.01%
94,775,00046,365,00030,960,00070,155,00048,404,00022,480,00029,504,00031,055,00015,168,00041,206,00041,381,00076,687,00075,064,00053,269,00059,859,00049,089,00085,828,00085,706,000129,531,000163,224,000
Dividend
Jul 01, 20242 CHF/sh
Earnings
May 20, 2025

Profile

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates in two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, patch injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through biotechnology and pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
IPO date
Sep 22, 2004
Employees
2,059
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
548,457
10.25%
497,460
7.02%
464,841
15.16%
Cost of revenue
467,394
489,115
462,398
Unusual Expense (Income)
NOPBT
81,063
8,345
2,443
NOPBT Margin
14.78%
1.68%
0.53%
Operating Taxes
3,506
5,362
2,435
Tax Rate
4.33%
64.25%
99.67%
NOPAT
77,557
2,983
8
Net income
78,366
52.83%
51,275
121.92%
23,105
297.61%
Dividends
(17,745)
(8,190)
(14,667)
Dividend yield
0.36%
0.32%
0.71%
Proceeds from repurchase of equity
(190)
34,458
791
BB yield
0.00%
-1.33%
-0.04%
Debt
Debt current
256,000
157,000
157,000
Long-term debt
(7,976)
110,000
Deferred revenue
7,976
7,739
Other long-term liabilities
40,216
30,072
(1,227)
Net debt
181,983
113,071
239,115
Cash flow
Cash from operating activities
163,224
129,531
85,706
CAPEX
(116,374)
(169,173)
(127,430)
Cash from investing activities
(195,072)
(122,019)
(125,700)
Cash from financing activities
81,066
1,265
38,124
FCF
15,022
(33,564)
(25,097)
Balance
Cash
74,017
25,224
17,038
Long term investments
10,729
10,847
Excess cash
46,594
11,080
4,643
Stockholders' equity
765,225
562,500
392,540
Invested Capital
867,358
744,062
668,966
ROIC
9.63%
0.42%
0.00%
ROCE
8.84%
1.10%
0.36%
EV
Common stock shares outstanding
13,652
13,419
12,684
Price
360.50
87.37%
192.40
18.04%
163.00
2.77%
Market cap
4,921,456
90.62%
2,581,751
24.87%
2,067,487
3.04%
EV
5,103,439
2,694,822
2,306,602
EBITDA
155,929
86,905
70,524
EV/EBITDA
32.73
31.01
32.71
Interest
5,038
2,310
2,265
Interest/NOPBT
6.21%
27.68%
92.71%